Status: current, Defined. Date: 31-Aug 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4151971000168119 | Soliqua 100/50 (insulin glargine 100 international units / 1 mL + lixisenatide 50 microgram / 1 mL) injection, 3 x 3 mL pen devices (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4151981000168116 | Soliqua 100/50 injection, 3 x 3 mL pen devices | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Soliqua 100/50 injection, 3 x 3 mL pen devices | Is a | insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, 3 x 3 mL pen devices | true | Inferred relationship | Some | ||
| Soliqua 100/50 injection, 3 x 3 mL pen devices | Is a | trade product pack | true | Inferred relationship | Some | ||
| Soliqua 100/50 injection, 3 x 3 mL pen devices | has TPUU | Soliqua 100/50 injection, 3 mL pen device | true | Inferred relationship | Some | 1 | |
| Soliqua 100/50 injection, 3 x 3 mL pen devices | has TP | Soliqua 100/50 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Soliqua 100/50 injection, 3 x 3 mL pen devices | Is a | True | Soliqua 100/50 injection, 3 x 3 mL pen devices | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR